DCBLD2 antibody

Catalog No. ABIN2423275

Product Details anti-DCBLD2 Antibody

Target: DCBLD2 (Discoidin, CUB and LCCL Domain Containing 2 (DCBLD2))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This DCBLD2 antibody is un-conjugated

Application: ELISA, Immunohistochemistry (IHC)

Purification: Affinity purification

Immunogen: Recombinant protein of human DCBLD2

Isotype: IgG

Application Details

Application Notes: IHC 1:100-1:300

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Preservative: Sodium azide

Handling Advice: Avoid freeze / thaw cycles.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for DCBLD2

Target: DCBLD2 (Discoidin, CUB and LCCL Domain Containing 2 (DCBLD2))

Alternative Name: DCBLD2 (DCBLD2 Products)

Synonyms: DCBLD2 antibody, zgc:158743 antibody, CLCP1 antibody, ESDN antibody, 1700055P21Rik antibody, AW146002 antibody, Esdn antibody, discoidin, CUB and LCCL domain containing 2 antibody, discoidin, CUB and LCCL domain-containing protein 2 antibody, DCBLD2 antibody, dcbld2 antibody, LOC100444682 antibody, Dcbld2 antibody

Background: CLCP1 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1), also known as DCBLD2 (discoidin, CUB and LCCL domain containing 2) or ESDN, is a 775 amino acid single-pass type I membrane protein that contains one CUB domain, one LCCL domain and one F5/8 type C domain. Expressed at high levels in heart, testis and skeletal muscle, CLCP1 is thought to regulate vascular smooth muscle cell (VSMC) proliferation and remodeling and may be involved in the transformation and metastasis of various cancers, such as metastatic lung cancer and gastric carcinoma.